Close

Show

Home Home

Home

Celerion Recognized as a Leading Contract Research Organization for the 4th Consecutive Year

Sygnature Discovery Continues Strong Growth Trajectory with Two Senior Appointments

CytoReason Signs Collaboration Agreement with Pfizer Inc. To Utilize CytoReason’s Machine Learning Model of the Immune System for Drug Discovery

GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus

GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination...

Contact Us